IMVT Shares Outstanding History



Below is a table of the IMVT shares outstanding history going back to 11/13/2019:

Date IMVT Shares Outstanding
11/13/201914.38M
2/14/202056.46M
6/29/202081.81M
8/12/202081.81M
11/12/202097.89M
2/16/202197.97M
6/1/202197.98M
8/9/2021115.00M
11/1/2021115.00M
2/1/2022116.40M
6/3/2022116.51M
7/29/2022116.58M
10/28/2022129.18M
1/27/2023130.25M
5/17/2023130.41M
8/4/2023130.67M
11/3/2023144.66M
2/5/2024145.29M

Also see: IMVT Market Cap History
IMVT YTD Return
IMVT Historical Shares Outstanding:
+72.72% CAGR
IMVT Historical Shares Outstanding: +72.72% CAGR

Mouse over chart for data details
11/13/2019 ...2/5/2024
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Co.'s product pipeline includes batoclimab and IMVT-1402, both of which are fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor. Co. is developing batoclimab, its first prodcut candidate, and IMVT-1402, its second product candidate, in autoimmune diseases for which there is evidence that pathogenic IgG antibodies drive disease manifestation. Co. is developing batoclimab for myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy and Graves' disease. We show 18 historical shares outstanding datapoints in our coverage of IMVT's shares outstanding history.

Understanding the changing numbers of IMVT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMVT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMVT by allowing them to research IMVT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree IMVT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Immunovant (IMVT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

INAB Shares Outstanding History
INBS Shares Outstanding History
INBX Shares Outstanding History
INCY Shares Outstanding History
INDP Shares Outstanding History
INFI Shares Outstanding History
INGN Shares Outstanding History
INKT Shares Outstanding History
INMB Shares Outstanding History
INNT Shares Outstanding History
More Healthcare companies »

 

IMVT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.